CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Cash Paid for Capitalized Interest (Deprecated 2011-01-31)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Cash Paid for Capitalized Interest (Deprecated 2011-01-31) of $92.00 thousand for the 3-month period ending 2011-03-26, per its 10-Q filed 2011-05-04.
Discontinued › Cash Flow
us-gaap:CashPaidForCapitalizedInterest · last filed 2011-05-04
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for the quarter ending 2011-03-26 was $92.00K, a 95.40% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for the quarter ending 2010-03-27 was $2.00M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for the quarter ending 2009-12-26 was $498.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for the quarter ending 2009-09-26 was $508.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for fiscal 2010 was $56.00K, a 97.76% decline from fiscal 2009.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for fiscal 2009 was $2.50M, a 52.57% decline from fiscal 2008.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash paid for capitalized interest (deprecated 2011-01-31) for fiscal 2008 was $5.26M.
| Period end | Cash Paid for Capitalized Interest (Deprecated 2011-01-31) 3 month | Cash Paid for Capitalized Interest (Deprecated 2011-01-31) 6 month | Cash Paid for Capitalized Interest (Deprecated 2011-01-31) 9 month | Cash Paid for Capitalized Interest (Deprecated 2011-01-31) 12 month |
|---|---|---|---|---|
| 2011-03-26 | $92.00K 10-Q · filed 2011-05-04 | |||
| 2010-12-25 | $56.00K 10-K · filed 2011-02-23 | |||
| 2010-03-27 | $2.00M 10-Q · filed 2011-05-04 | $2.50M derived: sum of 2 quarters · filed 2011-05-04 | $3.00M derived: sum of 3 quarters · filed 2011-05-04 | |
| 2009-12-26 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-23 | $1.01M derived: sum of 2 quarters · filed 2011-02-23 | $2.50M 10-K · filed 2011-02-23 | |
| 2009-09-26 | $508.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04 | $2.00M 10-Q · filed 2010-11-04 | ||
| 2009-06-27 | $1.49M 10-Q · filed 2010-08-03 | |||
| 2008-12-27 | $5.26M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |